© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003

References 5200-5299

5200. S. Tanaka, M. Iwai, Y. Harada, T. Morikawa, A. Muramatsu, T. Mori, T. Okanoue, K. Kashima, H. Maruyama-Tabata, H. Hirai, E. Satoh, J. Imanishi, O. Mazda, “Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter,” Cancer Gene Ther. 7(September 2000):1241-1250.

5201. D. Balicki, R.A. Reisfeld, U. Pertl, E. Beutler, H.N. Lode, “Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma,” Proc. Natl. Acad. Sci. (USA) 97(10 October 2000):11500-11504; http://www.pnas.org/cgi/content/full/97/21/11500

5202. H. Kobayashi, S. Kawamoto, T. Saga, N. Sato, T. Ishimori, J. Konishi, K. Ono, K. Togashi, M.W. Brechbiel, “Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI,” Bioconjug. Chem. 12(July-August 2001):587-593.

5203. P.K. Tripathi, A.J. Khopade, S. Nagaich, S. Shrivastava, S. Jain, N.K. Jain, “Dendrimer grafts for delivery of 5-fluorouracil,” Pharmazie 57(April 2002):261-264; R.X. Zhuo, B. Du, Z.R. Lu, “In vitro release of 5-fluorouracil with cyclic core dendritic polymer,” J. Control Release 57(22 February 1999):249-257.

5204. J.P. Tam, Y.A. Lu, J.L. Yang, “Antimicrobial dendrimeric peptides,” Eur. J. Biochem. 269(February 2002):923-932.

5205. C.Z. Chen, N.C. Beck-Tan, P. Dhurjati, T.K. van Dyk, R.A. LaRossa, S.L. Cooper, “Quaternary ammonium functionalized poly(propylene imine) dendrimers as effective antimicrobials: structure-activity studies,” Biomacromolecules 1(Fall 2000):473-480.

5206. J.D. Reuter, A. Myc, M.M. Hayes, Z. Gan, R. Roy, D. Qin, R. Yin, L.T. Piehler, R. Esfand, D.A. Tomalia, J.R. Baker Jr., “Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers,” Bioconjug. Chem. 10(March-April 1999):271-278.

5207. A. Gazumyan, B. Mitsner, G.A. Ellestad, “Novel anti-RSV dianionic dendrimer-like compounds: design, synthesis and biological evaluation,” Curr. Pharm. Des. 6(March 2000):525-546.

5208. N. Bourne, L.R. Stanberry, E.R. Kern, G. Holan, B. Matthews, D.I. Bernstein, “Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection,” Antimicrob. Agents Chemother. 44(September 2000):2471-2474; http://aac.asm.org/cgi/content/full/44/9/2471

5209. M. Witvrouw, V. Fikkert, W. Pluymers, B. Matthews, K. Mardel, D. Schols, J. Raff, Z. Debyser, E. De Clercq, G. Holan, C. Pannecouque, “Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle,” Mol. Pharmacol. 58(November 2000):1100-1108.

5210. V. Razinkov, A. Gazumyan, A. Nikitenko, G. Ellestad, G. Krishnamurthy, “RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein,” Chem. Biol. 8(July 2001):645-659.

5211. S. Supattapone, H. Wille, L. Uyechi, J. Safar, P. Tremblay, F.C. Szoka, F.E. Cohen, S.B. Prusiner, M.R. Scott, “Branched polyamines cure prion-infected neuroblastoma cells,” J. Virol. 75(April 2001):3453-3461.

5212. A.P. Schroeder, E. Falk, “Vulnerable and dangerous coronary plaques,” Atherosclerosis 118(December 1995):S141-S149.

5213. R.T. Lee, H. Huang, “Mechanotransduction and arterial smooth muscle cells: new insight into hypertension and atherosclerosis,” Ann. Med. 32(May 2000):233-235.

5214. H.B. Hangler, K. Pfaller, H. Antretter, O.E. Dapunt, J.O. Bonatti, “Coronary endothelial injury after local occlusion on the human beating heart,” Ann. Thorac. Surg. 71(January 2001):122-127, 73(January 2002):344-345 (comment).

5215. A. Kadar, S. Bjorkerud, “Arterial remodeling following mechanical injury. The role and nature of smooth muscle cells,” Pathol. Res. Pract. 180(October 1985):342-347.

5216. C.J. Schwartz, J.L. Kelley, R.M. Nerem, E.A. Sprague, M.M. Rozek, A.J. Valente, E.H. Edwards, A.R. Prasad, J.J. Kerbacher, S.A. Logan, “Pathophysiology of the atherogenic process,” Am. J. Cardiol. 64(3 October 1989):23G-30G.

5217. G.S. Abela, P.D. Picon, S.E. Friedl, O.C. Gebara, A. Miyamoto, M. Federman, G.H. Tofler, J.E. Muller, “Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model,” Circulation 91(1 February 1995):776-784; http://circ.ahajournals.org/cgi/content/full/91/3/776

5218. T. Oniki, M. Iwakami, “Is arterial remodeling truly a compensatory biological reaction? A mechanical deformation hypothesis,” Atherosclerosis 132(11 July 1997):115-118.

5219. G.D. Lowe, “The relationship between infection, inflammation, and cardiovascular disease: an overview,” Ann. Periodontol. 6(December 2001):1-8.

5220. D. Tang, C. Yang, S. Kobayashi, D.N. Ku, “Steady flow and wall compression in stenotic arteries: a three-dimensional thick-wall model with fluid-wall interactions,” J. Biomech. Eng. 123(December 2001):548-557.

5221. R.G. Schaub, J.C. Keith Jr., C.A. Simmons, C.A. Rawlings, “Smooth muscle proliferation in chronically injured canine pulmonary arteries is reduced by a potent platelet aggregation inhibitor U-53,059,” Thromb. Haemost. 53(24 June 1985):351-355; R.G. Schaub, J.C. Keith Jr., C.A. Rawlings, “Effect of acetylsalicylic acid on vascular damage and myointimal proliferation in canine pulmonary arteries subjected to chronic injury by Dirofilaria immitis,” Am. J. Vet. Res. 44(March 1983):449-454.

5222. R.G. Schaub, C.A. Rawlings, “Pulmonary vascular response during phases of canine heartworm disease: scanning electron microscopic study,” Am. J. Vet. Res. 41(July 1980):1082-1089.

5223. J.F. Munnell, J.S. Weldon, R.E. Lewis, D.E. Thrall, J.W. McCall, “Intimal lesions of the pulmonary artery in dogs with experimental dirofilariasis,” Am. J. Vet. Res. 41(July 1980):1108-1112.

5224. R.G. Schaub, C.A. Rawlings, J.C. Keith Jr., “Effect of long-term aspirin treatment on platelet adhesion to chronically damaged canine pulmonary arteries,” Thromb. Haemost. 46(23 December 1981):680-683.

5225. J.C. Keith Jr., R.G. Schaub, C. Rawlings, “Early arterial injury-induced myointimal proliferation in canine pulmonary arteries,” Am. J. Vet. Res. 44(February 1983):181-186.

5226. R.S. Crissman, J.N. Ross Jr., “Electron microscopy of intimal lesions in the pulmonary trunk of a dog with Dirofilaria immitis,” J. Submicrosc. Cytol. 15(April 1983):509-517.

5227. Jessica Gorman, “Taming high-tech particles,” Science News 161(30 March 2002):200; http://www.sciencenews.org/20020330/bob8.asp

5228. J.C. Lord, “Desiccant dusts synergize the effect of Beauveria bassiana (Hyphomycetes: Moniliales) on stored-grain beetles,” J. Econ. Entomol. 94(April 2001):367-372.

5229. “The environmental implications of nanotechnology,” Rice University, 2002; http://cnst.rice.edu/cben/NanoEnvi.shtml

5230. A. Huczko, H. Lange, E. Calko, H. Grubek-Jaworska, P. Droszez, T. Sogabe, “On some aspects of the bioactivity of fullerene nanostructures,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 271-274.

5231. Moonsub Shim, Nadine Wong Shi Kam, Robert J. Chen, Yiming Li, Hongjie Dai, “Functionalization of carbon nanotubes for biocompatibility and biomolecular recognition,” Nano Lett. 2(2002):285-288.

5232. I. Nakanishi, S. Fukuzumi, T. Konishi, K. Ohkubo, M. Fujitsuka, O. Ito, N. Miyata, “DNA cleavage via electron transfer from NADH to molecular oxygen photosensitized by g-cyclodextrin-bicapped C60,” in P.V. Kamat, D.M. Guldi, K.M. Kadish, eds., Fullerenes for the New Millennium, Volume 11, The Electrochemical Society, Spring 2001, pp. 138-151.

5233. N. Gharbi et al, “In vivo behavior of two C60 derivatives,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 240-243.

5234. C.F. Richardson, D.I. Schuster, S.R. Wilson, “Properties of water soluble fullerene derivatives,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 226-232.

5235. D.I. Schuster et al, “Evaluation of the anti-HIV potency of a water-soluble dendrimeric fullerene,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 267-270.

5236. T. Mashino, N. Usui, K. Okuda, T. Hirota, M. Hirobe, M. Mochizuki, “Inhibition of E. coli and cancer cell growth by fullerene derivatives and the inhibition mechanism,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 244-249.

5237. Y. Chi, S. Patil, T. Canteenwala, L.Y. Chiang, “Photogeneration of superoxide radicals and photodynamic effect of hydrophilic fullerene derivatives on tumors in vivo,” Paper No. 0497, Session N9 – Biochemical and Pharmaceutical Aspects of Fullerene Materials, 197th Meeting of The Electrochemical Society, Toronto, Canada, 14-19 May 2000.

5238. G. Andrievsky, A. Zhmuro, L. Zabobonina, E. Suchina, “First clinical case of treatment of patient (volunteer) with rectal adenocarcinoma by hydrated fullerenes: Natural course of the disease or non-specific anticancer activity?” Poster presentation No. 0377, Session N9 – Biochemical and Pharmaceutical Aspects of Fullerene Materials, 197th Meeting of The Electrochemical Society, Toronto, Canada, 14-19 May 2000.

5239. D.J. Wolff, A.D.P. Papoiu, K. Mialkowski, C.F. Richardson, D.I. Schuster, S.R. Wilson, “Water-soluble derivatives of C60 fullerene inhibit nitric oxide synthase,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 215-225.

5240. A.A. Golub, Yu.I. Prylutskyy, O.P. Matyshevska, S.V. Prylutska, V.Yu. Bardic, L.L. Ped, V.A. Kudrenko, E.O. Radchenko, P. Scharff, T. Braun, “Supramolecular composites of fullerenes immobilized at silica surface: Topology, structure and bioactivity,” Poster presentation No. 8-6.P., Intl. Conf. on Physics of Liquid Matter: Modern Problems (PLM MP)), Ministry of Science and Education of Ukraine, Kyiv, Ukraine, 14-19 September 2001, Section VIII, p. 160 (abstract only); http://www.plmmp.univ.kiev.ua/eng/html/abstr/sec08.pdf

5241. T. Wharton, J.M. Alford, L.O. Husebo, L.J. Wilson, “Paramagnetic malonodiamide derivatives of C60 as MRI contrast agent precursors,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 258-266.

5242. A.N. Kirschner, D.H. Santosa, S.R. Wilson, “Liposomes vs. carbon nanotubes as small molecule vessels for drug delivery,” in N. Martin, M. Maggini, D.M. Guldi, eds., Fullerenes 2000, Volume 9: Functionalized Fullerenes, The Electrochemical Society, Spring 2000, pp. 250-257.

5243. D.A. Walters, B.L. Smith, A.M. Belcher, G.T. Paloczi, G.D. Stucky, D.E. Morse, P.K. Hansma, “Modification of calcite crystal growth by abalone shell proteins: an atomic force microscope study,” Biophys. J. 72(March 1997):1425-1433.

5244. J.B. Thompson, G.T. Paloczi, J.H. Kindt, M. Michenfelder, B.L. Smith, G. Stucky, D.E. Morse, P.K. Hansma, “Direct observation of the transition from calcite to aragonite growth as induced by abalone shell proteins,” Biophys. J. 79(December 2000):3307-3312; http://www.biophysj.org/cgi/content/full/79/6/3307

5245. C.F. Verkoelen, B.G. Van Der Boom, J.C. Romijn, “Identification of hyaluronan as a crystal-binding molecule at the surface of migrating and proliferating MDCK cells,” Kidney Int. 58(September 2000):1045-1054. See also: C.F. Verkoelen, B.G. van der Boom, A.B. Houtsmuller, F.H. Schroder, J.C. Romijn, “Increased calcium oxalate monohydrate crystal binding to injured renal tubular epithelial cells in culture,” Am. J. Physiol. 274(May 1998):F958-F965; http://ajprenal.physiology.org/cgi/content/full/274/5/F958

5246. M. Bruchez Jr., M. Moronne, P. Gin, S. Weiss, A.P. Alivisatos, “Semiconductor nanocrystals as fluorescent biological labels,” Science 281(25 September 1998):2013-2016, 1930-1931 (comment).

5247. T.D. Lacoste, X. Michalet, F. Pinaud, D.S. Chemla, A.P. Alivisatos, S. Weiss, “Ultrahigh-resolution multicolor colocalization of single fluorescent probes,” Proc. Natl. Acad. Sci. (USA) 97(15 August 2000):9461-9466; http://www.pnas.org/cgi/content/full/97/17/9461

5248. W.C. Chan, S. Nie, “Quantum dot bioconjugates for ultrasensitive nonisotopic detection,” Science 281(25 September 1998):2016-2018, 1930-1931 (comment).

5249. M. Han, X. Gao, J.Z. Su, S. Nie, “Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules,” Nat. Biotechnol. 19(July 2001):631-635, 621-622 (comment).

5250. Quantum Dot Corp.; http://www.qdots.com/new/technology/dottech.html

5251. E. Klarreich, “Biologists join the dots,” Nature 413(4 October 2001):450-452.

5252. C.Y. Tan, R.Q. Liang, K.C. Ruan, “Application of quantum dot to life science,” Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(January 2002):1-5. In Chinese.

5253. W.C. Chan, D.J. Maxwell, X. Gao, R.E. Bailey, M. Han, S. Nie, “Luminescent quantum dots for multiplexed biological detection and imaging,” Curr. Opin. Biotechnol. 13(February 2002):40-46; X. Gao, W.C. Chan, S. Nie, “Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding,” J. Biomed. Opt. 7(October 2002):532-537.

5254. S.B. Jonnalagadda, P.V. Rao, “Toxicity, bioavailability and metal speciation,” Comp. Biochem. Physiol. C 106(November 1993):585-595; J.D. Robertson, S. Orrenius, “Molecular mechanisms of apoptosis induced by cytotoxic chemicals,” Crit. Rev. Toxicol. 30(September 2000):609-627; E. Marth, S. Jelovcan, B. Kleinhappl, A. Gutschi, S. Barth, “The effect of heavy metals on the immune system at low concentrations,” Int. J. Occup. Med. Environ. Health 14(2001):375-386.

5255. M.A. Ruegsegger, R.E. Marchant, “Reduced protein adsorption and platelet adhesion by controlled variation of oligomaltose surfactant polymer coatings,” J. Biomed. Mater. Res. 56(August 2001):159-167.

5256. R.E. Marchant, S. Yuan, G. Szakalas-Gratzl, “Interactions of plasma proteins with a novel polysaccharide surfactant physisorbed to polyethylene,” J. Biomater. Sci. Polym. Ed. 6(1994):549-564.

5257. K. Fujimoto, H. Tadokoro, Y. Ueda, Y. Ikada, “Polyurethane surface modification by graft polymerization of acrylamide for reduced protein adsorption and platelet adhesion,” Biomaterials 14(May 1993):442-448.

5258. J.H. Lee, S.H. Oh, “MMA/MPEOMA/VSA copolymer as a novel blood-compatible material: effect of PEO and negatively charged side chains on protein adsorption and platelet adhesion,” J. Biomed. Mater. Res. 60(April 2002):44-52.

5259. F. Zhang, E.T. Kang, K.G. Neoh, W. Huang, “Modification of gold surface by grafting of poly(ethylene glycol) for reduction in protein adsorption and platelet adhesion,” J. Biomater. Sci. Polym. Ed. 12(2001):515-531.

5260. D. Beyer, W. Knoll, H. Ringsdorf, J.H. Wang, R.B. Timmons, P. Sluka, “Reduced protein adsorption on plastics via direct plasma deposition of triethylene glycol monoallyl ether,” J. Biomed. Mater. Res. 36(August 1997):181-189.

5261. A. Hall, C.D. Nobes, “Rho GTPases: molecular switches that control the organization and dynamics of the actin cytoskeleton,” Philos. Trans. R. Soc. Lond. B Biol. Sci. 355(29 July 2000):965-970.

5262. Barbara Conradt, “With a little help from your friends: cells don’t die alone,” Nat. Cell Biol. 4(June 2002):E139-E143; http://www.nature.com/ncblink/v4/n6/full/ncb0602-e139.html

5263. S. Majumdar, H. Kaur, H. Vohra, G.C. Varshney, “Membrane surface of Mycobacterium microti-infected macrophages antigenically differs from that of uninfected macrophages,” FEMS Immunol. Med. Microbiol. 28(May 2000):71-77.

5264. P.M. Allen, D.I. Beller, J. Braun, E.R. Unanue, “The handling of Listeria monocytogenes by macrophages: the search for an immunogenic molecule in antigen presentation,” J. Immunol. 132(January 1984):323-331; P.M. Allen, E.R. Unanue, “Antigen processing and presentation by macrophages,” Am. J. Anat. 170(July 1984):483-490.

5265. Cindy Belles, Alicia Kuhl, Rachel Nosheny, Simon R. Carding, “Plasma membrane expression of heat shock protein 60 in vivo in response to infection,” Infect. Immun. 67(August 1999):4191-4200; http://iai.asm.org/cgi/content/full/67/8/4191

5266. F.T. Liang, A.C. Steere, A.R. Marques, B.J. Johnson, J.N. Miller, M.T. Philipp, “Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE,” J. Clin. Microbiol. 37(December 1999):3990-3996; http://jcm.asm.org/cgi/content/full/37/12/3990

5267. F.T. Liang, E. Aberer, M. Cinco, L. Gern, C.M. Hu, Y.N. Lobet, M. Ruscio, P.E. Voet Jr., V.E. Weynants, M.T. Philipp, “Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL,” J. Infect. Dis. 182(November 2000):1455-1462.

5268. M.T. Philipp, L.C. Bowers, P.T. Fawcett, M.B. Jacobs, F.T. Liang, A.R. Marques, P.D. Mitchell, J.E. Purcell, M.S. Ratterree, R.K. Straubinger, “Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans,” J. Infect. Dis. 184(1 October 2001):870-878.

5269. M.J. Mathiesen, A. Holm, M. Christiansen, J. Blom, K. Hansen, S. Ostergaard, M. Theisen, “The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif,” Infect. Immun. 66(September 1998):4073-4079; http://iai.asm.org/cgi/content/full/66/9/4073

5270. C. Eicken, V. Sharma, T. Klabunde, R.T. Owens, D.S. Pikas, M. Hook, J.C. Sacchettini, “Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi,” J. Biol. Chem. 276(30 March 2001):10010-10015; http://www.jbc.org/cgi/content/full/276/13/10010

5271. M. Ikushima, K. Matsui, F. Yamada, S. Kawahashi, S.K. Nishikawa, “Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies,” FEMS Immunol. Med. Microbiol. 29(September 2000):15-21.

5272. W.S. Probert, K.M. Allsup, R.B. LeFebvre, “Identification and characterization of a surface-exposed, 66-kilodalton protein from Borrelia burgdorferi,” Infect. Immun. 63(May 1995):1933-1939; http://iai.asm.org/cgi/reprint/63/5/1933

5273. M. Labandeira-Rey, E.A. Baker, J.T. Skare, “VraA (BBI16) protein of Borrelia burgdorferi is a surface-exposed antigen with a repetitive motif that confers partial protection against experimental Lyme borreliosis,” Infect. Immun. 69(March 2001):1409-1419; http://iai.asm.org/cgi/content/full/69/3/1409

5274. J. Satulovsky, M.A. Carignano, I. Szleifer, “Kinetic and thermodynamic control of protein adsorption.” Proc. Natl. Acad. Sci. (USA) 97(1 August 2000):9037-9041; http://www.pnas.org/cgi/content/full/97/16/9037

5275. J.D. Andrade, ed., Surface and Interfacial Aspects Of Biomedical Polymers, Plenum, New York, 1985.

5276. V.P. Torchilin, V.S. Trubetskoy, “Which polymers can make nanoparticulate drug carriers long-circulating,” Adv. Drug Delivery Rev. 16(September 1995):141-155.

5277. J. Milton Harris, S. Zalipsky, eds., Poly(ethylene glycol): Chemistry and Biological Applications, American Chemical Society, Washington, DC, 1997.

5278. D. Needham, T.J. McIntosh, S.A. Simon, D. Zhelev, “Adsorption, molecular exchange and defect formation in membranes,” Curr. Opin. Colloid Interface Sci. 3(October 1998):511-517.

5279. A. Halperin, M. Tirrell, T.P. Lodge, “Tethered chains in polymer microstructures,” Adv. Pol. Sci. 100(1992):31-71; T. McPherson, A. Kidane, I. Szleifer, K. Park, “Prevention of protein adsorption by tethered poly(ethylene oxide) layers: Experiments and single-chain mean-field analysis,” Langmuir 14(6 January 1998):176-186.

5280. D. Lasic, F. Martin, eds., Stealth Liposomes, CRC, Boca Raton, FL, 1995; L. Fisher, D. Lasic, Curr. Opin. Colloid Interface Sci. 3(October 1998):509-510.

5281. A. Vertut-Doi, H. Ishiwata, K. Miyajima, “Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight,” Biochim Biophys Acta 1278(12 January 1996):19-28.

5282. H. Takeuchi, H. Kojima, H. Yamamoto, Y. Kawashima, “Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats,” J. Control Release 75(10 July 2001):83-91.

5283. A.N. Gordon, C.O. Granai, P.G. Rose, J. Hainsworth, A. Lopez, C. Weissman, R. Rosales, T. Sharpington, “Phase II study of liposomal doxorubicin in platinum- and paclitaxel-refractory epithelial ovarian cancer,” J. Clin. Oncol. 18(September 2000):3093-3100.

5284. M.I. Koukourakis, S. Koukouraki, I. Fezoulidis, N. Kelekis, G. Kyrias, S. Archimandritis, N. Karkavitsas, “High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours.” Br. J. Cancer 83(November 2000):1281-1286.

5285. M.R. Ranson, S. Cheeseman, S. White, J. Margison, “Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer,” Crit. Rev. Oncol. Hematol. 37(February 2001):115-120.

5286. E. Rivera, V. Valero, L. Syrewicz, Z. Rahman, F.L. Esteva, R.L. Theriault, M.M. Rosales, D. Booser, J.L. Murray, R.C. Bast Jr., G.N. Hortobagyi, “Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer,” J. Clin. Oncol. 19(15 March 2001):1716-1722.

5287. G.J. Veal, M.J. Griffin, E. Price, A. Parry, G.S. Dick, M.A. Little, S.M. Yule, B. Morland, E.J. Estlin, J.P. Hale, A.D. Pearson, H. Welbank, A.V. Boddy, “A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin,” Br. J. Cancer 84(20 April 2001):1029-1035.

5288. W. Linkesch, M. Weger, I. Eder, H.W. Auner, C. Pernegg, C. Kraule, M.J. Czejka, “Long-term pharmacokinetics of doxorubicin HCl stealth liposomes in patients after polychemotherapy with vinorelbine, cyclophosphamide and prednisone (CCVP),” Eur. J. Drug Metab. Pharmacokinet. 26(July-September 2001):179-184.

5289. S.R. Johnston, M.E. Gore, “Caelyx: phase II studies in ovarian cancer,” Eur. J. Cancer 37(December 2001):S8-S14 (Suppl 9).

5290. J.M. Meerum Terwogt, G. Groenewegen, D. Pluim, M. Maliepaard, M.M. Tibben, A. Huisman, W.W. ten Bokkel Huinink, M. Schot, H. Welbank, E.E. Voest, J.H. Beijnen, J.M. Schellens, “Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin,” Cancer Chemother. Pharmacol. 49(March 2002):201-210.

5291. S.K. Hendricks, C. Kwok, M. Shen, T.A. Horbett, B.D. Ratner, J.D. Bryers, “Plasma-deposited membranes for controlled release of antibiotic to prevent bacterial adhesion and biofilm formation,” J. Biomed. Mater. Res. 50(May 2000):160-170.

5292. B.D. Ratner, “Blood compatibility – a perspective,” J. Biomater. Sci. Polym. Ed. 11(2000):1107-1119.

5293. B.D. Ratner, “Reducing capsular thickness and enhancing angiogenesis around implant drug release systems,” J. Control Release 78(17 January 2002):211-218.

5294. B.D. Ratner, “Replacing and renewing: synthetic materials, biomimetics, and tissue engineering in implant dentistry,” J. Dent. Educ. 65(December 2001):1340-1347.

5295. M. Shen, Y.V. Pan, M.S. Wagner, K.D. Hauch, D.G. Castner, B.D. Ratner, T.A. Horbett, “Inhibition of monocyte adhesion and fibrinogen adsorption on glow discharge plasma deposited tetraethylene glycol dimethyl ether,” J. Biomater. Sci. Polym. Ed. 12(2001):961-978.

5296. T. Mizutani, T. Murakami, T. Kurahashi, H. Ogoshi, “An artificial receptor for dimethyl aspartate,” J. Org. Chem. 61(26 January 1996):539-548.

5297. B. Linton, A.D. Hamilton, “Formation of artificial receptors by metal-templated self-assembly,” Chem. Rev. 97(5 August 1997):1669-1680.

5298. M. Inouye, Y. Hyodo, H. Nakazumi, “Nucleobase recognition by artificial receptors possessing a ferrocene skeleton as a novel modular unit for hydrogen bonding and stacking interactions,” J. Org. Chem. 64(16 April 1999):2704-2710.

5299. I. Hamachi, J.I. Watanabe, R. Eboshi, T. Hiraoka, S. Shinkai, “Incorporation of artificial receptors into a protein/peptide,” Biopolymers 55(2000):459-468.

Last updated on 16 April 2004